1. Zhu, Huiping, Enaw, James O Ebot, Ma, Chen, Lammer, Edward J, Finnell, Richard H. 2007. Association between CFL1 gene polymorphisms and spina bifida risk in a California population. In BMC medical genetics, 8, 12. doi:. https://pubmed.ncbi.nlm.nih.gov/17352815/
2. Halder, Sajal Kumar, Rafi, Md Oliullah, Shahriar, Esha Binte, Himel, Mahbubul Kabir, Emran, Talha Bin. 2022. Identification of the most damaging nsSNPs in the human CFL1 gene and their functional and structural impacts on cofilin-1 protein. In Gene, 819, 146206. doi:10.1016/j.gene.2022.146206. https://pubmed.ncbi.nlm.nih.gov/35092861/
3. Li, Rui, Zhao, Hongzhe, Huang, Xudong, Lin, Dongxin, Zheng, Jian. 2023. Super-enhancer RNA m6A promotes local chromatin accessibility and oncogene transcription in pancreatic ductal adenocarcinoma. In Nature genetics, 55, 2224-2234. doi:10.1038/s41588-023-01568-8. https://pubmed.ncbi.nlm.nih.gov/37957340/
4. Daryabari, Seyedeh Saideh, Fathi, Marziyeh, Mahdavi, Majid, Shokoohi, Behrouz, Safaralizadeh, Reza. 2020. Overexpression of CFL1 in gastric cancer and the effects of its silencing by siRNA with a nanoparticle delivery system in the gastric cancer cell line. In Journal of cellular physiology, 235, 6660-6672. doi:10.1002/jcp.29562. https://pubmed.ncbi.nlm.nih.gov/31990066/
5. Castro, Mauro Antonio Alves, Dal-Pizzol, Felipe, Zdanov, Stephanie, Shacter, Emily, Klamt, Fábio. . CFL1 expression levels as a prognostic and drug resistance marker in nonsmall cell lung cancer. In Cancer, 116, 3645-55. doi:10.1002/cncr.25125. https://pubmed.ncbi.nlm.nih.gov/20564088/
6. Yao, Bowen, Li, Yazhao, Chen, Tianxiang, Liu, Qingguang, Tu, Kangsheng. . Hypoxia-induced cofilin 1 promotes hepatocellular carcinoma progression by regulating the PLD1/AKT pathway. In Clinical and translational medicine, 11, e366. doi:10.1002/ctm2.366. https://pubmed.ncbi.nlm.nih.gov/33784016/
智鼠故事 
